A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Head and Neck Squamous Cell Carcinoma|Colorectal Cancer|Prostate Cancer|Ovarian Cancer|Urothelial Carcinoma|Non-small Cell Lung Cancer
Interventions: DRUG: ONM-100
Sponsor: OncoNano Medicine, Inc.